Taysha Gene Therapies Inc.
TSHA | NASDAQ
$5.21
+$0.17 (+3.37%)
Sep 22, 2026, 11:34 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -149.63M | -129.88M | -109M | -99.93M | -92.72M | -86.77M | -89.3M | -22.77M | -114.34M | -118.01M | -111.57M | -215.03M | -124.47M | -133.96M | -166.66M | -161.32M | -185.98M | -192.82M | -174.52M | -142.46M | -106.31M | -86.6M |
Depreciation & Amortization | 1.17M | 1.16M | 1.15M | 1.15M | 1.16M | 1.2M | 1.25M | 1.31M | 1.34M | 1.37M | 1.37M | 1.37M | 1.32M | 1.25M | 1.17M | 1.02M | 908K | 720K | 492K | 289K | 126K | 41K |
Stock-Based Compensation | 18.17M | 15.55M | 13.3M | 12.99M | 13.06M | 13.2M | 13.1M | 11.86M | 10.54M | 9.43M | 7.91M | 10.04M | 12.47M | 14.39M | 18.04M | 18.9M | 19.51M | 19.92M | 18.18M | 15.24M | 11.5M | 6.95M |
Other Working Capital | -4.7M | -5.68M | -5.22M | -1.37M | -9.45M | -11.34M | -9.55M | -12.07M | -14.15M | -14.04M | -15.72M | 20M | 25.96M | 20.65M | 25.5M | -3.06M | -5.97M | 14.67M | 14.17M | 7.53M | 8.47M | -3.99M |
Other Non-Cash Items | 1.02M | 6.69M | 6.83M | 2.02M | 7.19M | 6.24M | 6.19M | -50.78M | -53.85M | -49.84M | -49.86M | 45.58M | 43.13M | 39.6M | 40.92M | 5.84M | 6.73M | 6.39M | 10.14M | 10.2M | 11.69M | 28.71M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.93M | 97.14M | 97.14M | 97.14M | 101.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -2.92M | -5.47M | -5.37M | -900K | -10.81M | -17.32M | -12.47M | -14.71M | -16.2M | -12.72M | -18.01M | 14.34M | 14.07M | 10.66M | 17.7M | -7.79M | 12.35M | 29.84M | 28.67M | 20.09M | 11.58M | -160K |
Operating Cash Flow | -132.19M | -111.95M | -93.09M | -84.68M | -82.13M | -83.45M | -81.23M | -79.03M | -75.37M | -72.63M | -73.02M | -42.62M | -53.49M | -68.07M | -88.83M | -143.36M | -146.48M | -135.95M | -117.04M | -96.63M | -71.42M | -51.07M |
Capital Expenditures | -3.38M | -3.38M | -738K | -486K | -413K | -612K | -374K | -393K | -3.86M | -3.61M | -7.37M | -9.66M | -9.18M | -17.34M | -24.87M | -31.08M | -32.06M | -32.45M | -21.55M | -19.09M | -15.11M | -6.62M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -2.94M | -2.87M | 134K | 142K | 82K | 18K | 11K | 7K | 17K | 17K | 17K | -51K | -1.06M | -1.31M | -4.31M | -4.5M | -4M | -9.25M | -6.25M | -12M | -11.5M | -9M |
Investing Cash Flow | -3.32M | -3.26M | -604K | -344K | -331K | -594K | -363K | -386K | -3.84M | -3.59M | -7.35M | -9.71M | -9.24M | -17.4M | -24.93M | -31.08M | -32.06M | -32.45M | -21.55M | -19.09M | -15.11M | -9.62M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.85M | -3.85M | -3.85M | -3.85M | n/a | n/a | n/a | n/a | 9.98M | 39.96M | 39.96M | 39.96M | 29.98M | -28K | -27K |
Common Stock Repurchased | -173K | -173K | -173K | -173K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 9.01M | 9.05M | 8.9M | 8.96M | -70K | -201K | -96K | -75K | -90K | 300K | -48K | -9K | -33K | 10.67M | 10.93M | 9.99M | 10.09M | -981K | -874K | -95.82M | 71.61M | 71.35M |
Financial Cash Flow | 275.72M | 275.35M | 274.59M | 224.68M | 222.47M | 76.65M | 76.68M | 72.79M | 206.83M | 136.74M | 136.39M | 182.31M | 41.57M | 52.27M | 52.53M | 19.97M | 50.05M | 38.98M | 39.08M | 28.5M | 272.7M | 273.04M |
Net Cash Flow | 140.21M | 160.15M | 180.9M | 139.66M | 140.02M | -7.39M | -4.9M | -6.63M | 127.62M | 60.52M | 56.02M | 129.97M | -21.16M | -33.21M | -61.22M | -154.47M | -128.49M | -129.42M | -99.51M | -87.22M | 186.17M | 212.36M |
Free Cash Flow | -135.57M | -115.33M | -93.83M | -85.16M | -82.54M | -84.06M | -81.6M | -79.43M | -79.23M | -76.24M | -80.39M | -52.29M | -62.67M | -85.41M | -113.69M | -174.44M | -178.55M | -168.39M | -138.6M | -115.72M | -86.53M | -57.68M |
Adj. Free Cash Flow | -153.74M | -130.88M | -107.13M | -98.15M | -95.6M | -97.26M | -94.7M | -91.28M | -89.76M | -85.67M | -88.29M | -62.33M | -75.14M | -99.8M | -131.74M | -193.34M | -198.06M | -188.31M | -156.78M | -130.96M | -98.03M | -64.63M |
Maintenance CapEx | -404K | -403K | -486K | -484K | -411K | -612K | -374K | -376K | -341K | -44K | 96K | 96K | -2.92M | -11.13M | -22.56M | -22.77M | -19.92M | -11.89M | -492K | -289K | -126K | -41K |
Growth CapEx | -2.98M | -2.98M | -252K | -2K | -2K | n/a | n/a | -17K | -3.52M | -3.57M | -7.47M | -9.76M | -6.26M | -6.21M | -2.31M | -8.31M | -12.15M | -20.56M | -21.06M | -18.8M | -14.99M | -6.58M |
Owner Earnings | -132.6M | -112.35M | -93.58M | -85.16M | -82.54M | -84.06M | -81.6M | -79.41M | -75.71M | -72.68M | -72.92M | -42.53M | -56.41M | -79.2M | -111.39M | -166.13M | -166.4M | -147.83M | -117.53M | -96.92M | -71.54M | -51.11M |
Add to Watchlist
Select watchlists to add or remove TSHA